Holdings
Pharmaceuticals Ultrasector Profund
As of Jul 31, 2026, Pharmaceuticals Ultrasector Profund reported 64 positions worth US$6.06M. Largest: Crinetics Pharmaceuticals, Inc., Mbx Biosciences, Inc. and Ataibeckley Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | 2,675 | US$223K | +1,474 | Jul 31, 2026 |
| Mbx Biosciences, Inc. | 2,963 | US$195K | +1,453 | Jul 31, 2026 |
| Ataibeckley Inc. | 24,288 | US$174K | new | Jul 31, 2026 |
| Definium Therapeutics, Inc. | 3,950 | US$172K | +1,567 | Jul 31, 2026 |
| Amylyx Pharmaceuticals, Inc. | 6,821 | US$139K | +3,847 | Jul 31, 2026 |
| Enliven Therapeutics, Inc. | 2,481 | US$136K | +1,035 | Jul 31, 2026 |
| Corcept Therapeutics Incorporated | 1,175 | US$135K | −141 | Jul 31, 2026 |
| Alumis Inc. | 4,577 | US$129K | +2,891 | Jul 31, 2026 |
| Nuvation Bio Inc. | 20,045 | US$127K | +10,372 | Jul 31, 2026 |
| Trevi Therapeutics, Inc. | 6,851 | US$125K | +3,133 | Jul 31, 2026 |